Novo Nordisk

For 95 years, Novo Nordisk, a global leader in diabetes care, has been committed to discovering and developing innovative medicines to help people with chronic diseases lead longer, healthier lives.

---

Featured Products

  

---

Literature 

Ozempic and cardiovascular outcomes in patients with type 2 diabetes

Ozempic versus Trulicity once weekly in patients with type 2 diabetes: a randomized, open-label phase 3b trial

 

---